APA

Sheehan K. M., O'Donovan D. G., Fitzmaurice G., O'Grady A., O'Donoghue D. P., Sheahan K., Byrne M. F., Conroy R. M., Kay E. W. & Murray F. E. (20030529). Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer. : European journal of gastroenterology & hepatology.

Chicago

Sheehan Katherine M, O'Donovan Deirdre G, Fitzmaurice Gillian, O'Grady Anthony, O'Donoghue Diarmuid P, Sheahan Kieran, Byrne Michael F, Conroy Ronan M, Kay Elaine W and Murray Frank E. 20030529. Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer. : European journal of gastroenterology & hepatology.

Harvard

Sheehan K. M., O'Donovan D. G., Fitzmaurice G., O'Grady A., O'Donoghue D. P., Sheahan K., Byrne M. F., Conroy R. M., Kay E. W. and Murray F. E. (20030529). Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer. : European journal of gastroenterology & hepatology.

MLA

Sheehan Katherine M, O'Donovan Deirdre G, Fitzmaurice Gillian, O'Grady Anthony, O'Donoghue Diarmuid P, Sheahan Kieran, Byrne Michael F, Conroy Ronan M, Kay Elaine W and Murray Frank E. Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer. : European journal of gastroenterology & hepatology. 20030529.